Reata Pharmaceuticals Inc 2R3.DU Stock
161 EUR
{{ price }}
0.000000%
{{change_pct}}%
COUNTRY
Germany
Exchange
Dusseldorf
Market Cap
0 EUR
LOW - HIGH [24H]
0.0000
-
0.0000 EUR
VOLUME [24H]
0 EUR
{{ volume }}
P/E Ratio
0
Earnings per share
0 EUR
Reata Pharmaceuticals Inc Price Chart
Reata Pharmaceuticals Inc 2R3.DU Financial and Trading Overview
| Reata Pharmaceuticals Inc stock price | 161 EUR |
| Previous Close | 82 EUR |
| Open | 84 EUR |
| Bid | 83.5 EUR x N/A |
| Ask | 86.5 EUR x N/A |
| Day's Range | 84 - 84 EUR |
| 52 Week Range | 18.2 - 95.5 EUR |
| Volume | 50 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
2R3.DU Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Reata Pharmaceuticals Inc Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 95.5 EUR |
| 52 Week Low | 18.2 EUR |
| 50-Day Moving Average | 84.78 EUR |
| 200-Day Moving Average | 50.24 EUR |
2R3.DU Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | N/A |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | N/A |
| Operating Margin (ttm) | N/A |
| Gross Margin | N/A |
| EBITDA Margin | N/A |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Q&A For Reata Pharmaceuticals Inc Stock
What is a current 2R3.DU stock price?
Reata Pharmaceuticals Inc 2R3.DU stock price today per share is 161 EUR.
How to purchase Reata Pharmaceuticals Inc stock?
You can buy 2R3.DU shares on the Dusseldorf exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Reata Pharmaceuticals Inc?
The stock symbol or ticker of Reata Pharmaceuticals Inc is 2R3.DU.
How many shares does Reata Pharmaceuticals Inc have in circulation?
The max supply of Reata Pharmaceuticals Inc shares is 0.
What is Reata Pharmaceuticals Inc Price to Earnings Ratio (PE Ratio)?
Reata Pharmaceuticals Inc PE Ratio is 0.00000000 now.
What was Reata Pharmaceuticals Inc earnings per share over the trailing 12 months (TTM)?
Reata Pharmaceuticals Inc EPS is 0 EUR over the trailing 12 months.